Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Zoetis Share Holder Equity 2011-2024 | ZTS

Zoetis share holder equity from 2011 to 2024. Share holder equity can be defined as the sum of preferred and common equity items
  • Zoetis share holder equity for the quarter ending December 31, 2024 was $4.770B, a 4.43% decline year-over-year.
  • Zoetis share holder equity for 2024 was $4.77B, a 4.43% decline from 2023.
  • Zoetis share holder equity for 2023 was $4.991B, a 13.35% increase from 2022.
  • Zoetis share holder equity for 2022 was $4.403B, a 3.1% decline from 2021.
  
Zoetis Annual Share Holder Equity
(Millions of US $)
2024 $4,770
2023 $4,991
2022 $4,403
2021 $4,544
2020 $3,773
2019 $2,708
2018 $2,185
2017 $1,786
2016 $1,499
2015 $1,091
2014 $1,337
2013 $962
2012 $4,041
2011 $3,736
2010 $0
Zoetis Quarterly Share Holder Equity
(Millions of US $)
2024-12-31 $4,770
2024-09-30 $5,234
2024-06-30 $4,960
2024-03-31 $5,052
2023-12-31 $4,991
2023-09-30 $5,074
2023-06-30 $4,621
2023-03-31 $4,491
2022-12-31 $4,403
2022-09-30 $4,662
2022-06-30 $4,580
2022-03-31 $4,658
2021-12-31 $4,544
2021-09-30 $4,681
2021-06-30 $4,352
2021-03-31 $4,092
2020-12-31 $3,773
2020-09-30 $3,607
2020-06-30 $2,987
2020-03-31 $2,753
2019-12-31 $2,708
2019-09-30 $2,678
2019-06-30 $2,411
2019-03-31 $2,317
2018-12-31 $2,185
2018-09-30 $2,118
2018-06-30 $1,982
2018-03-31 $1,975
2017-12-31 $1,786
2017-09-30 $2,019
2017-06-30 $1,746
2017-03-31 $1,635
2016-12-31 $1,499
2016-09-30 $1,598
2016-06-30 $1,371
2016-03-31 $1,187
2015-12-31 $1,091
2015-09-30 $1,254
2015-06-30 $1,202
2015-03-31 $1,305
2014-12-31 $1,337
2014-09-30 $1,389
2014-06-30 $1,283
2014-03-31 $1,099
2013-12-31 $962
2013-09-30 $866
2013-06-30 $823
2013-03-31 $724
2012-12-31 $4,041
2012-09-30 $0
2012-06-30 $0
2012-03-31 $0
2011-12-31 $3,736
2010-12-31 $0
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $73.729B $9.256B
Zoetis Inc. is a leader in the animal health space with a focus on both livestock and companion animals in seven major product categories: vaccines, anti-infectives, parasiticides, dermatology, other pharmaceutical products, medicated feed additives and animal health diagnostics. Zoetis has a diversified business, which caters to eight core species ' cattle, swine, poultry, fish and sheep (collectively, livestock) and dogs, cats and horses (collectively, companion animals). It directly markets its products to veterinarians and livestock producers. The outstanding growth rate in the companion animal medicines, vaccines and diagnostics sector is being driven by economic development, related increases in disposable income and a rise in pet ownership and spending on pet care.Zoetis has been working on strengthening its product portfolio through acquisitions and deals.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $74.838B 29.53
Takeda Pharmaceutical (TAK) Japan $47.315B 10.47
Daiichi Sankyo, - (DSNKY) Japan $45.571B 27.77
Sandoz Group AG (SDZNY) Switzerland $18.445B 0.00
Merck (MKKGY) Germany $17.719B 14.66
Astellas Pharma (ALPMY) Japan $17.481B 12.39
Summit Therapeutics (SMMT) United States $14.230B 0.00
United Therapeutics (UTHR) United States $13.845B 12.53
Shionogi (SGIOY) Japan $12.760B 12.78
Corcept Therapeutics (CORT) United States $12.051B 92.11
Neurocrine Biosciences (NBIX) United States $11.027B 33.62
IPSEN (IPSEY) France $9.797B 0.00
Orion OYJ (ORINY) Finland $8.460B 23.98
Madrigal Pharmaceuticals (MDGL) United States $7.314B 0.00
Stevanato Group S.p.A (STVN) Italy $6.184B 39.27
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.813B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.254B 10.76
Grifols, S.A (GRFS) Spain $4.889B 0.00
Ionis Pharmaceuticals (IONS) United States $4.796B 0.00
Soleno Therapeutics (SLNO) United States $3.277B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.121B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.945B 12.01
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.598B 16.11
NewAmsterdam Pharma (NAMS) Netherlands $2.248B 0.00
Hypermarcas (HYPMY) Brazil $2.131B 8.41
Recursion Pharmaceuticals (RXRX) United States $2.127B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.915B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.567B 0.00
Guardian Pharmacy Services (GRDN) United States $1.346B 0.00
Indivior (INDV) United States $1.314B 5.71
ARS Pharmaceuticals (SPRY) United States $1.234B 157.25
Evotec AG (EVO) Germany $1.184B 0.00
Dyne Therapeutics (DYN) United States $1.183B 0.00
Ardelyx (ARDX) United States $1.170B 0.00
Ocular Therapeutix (OCUL) United States $1.166B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.104B 44.67
Enliven Therapeutics (ELVN) United States $0.964B 0.00
Collegium Pharmaceutical (COLL) United States $0.959B 5.09
Harrow (HROW) United States $0.948B 0.00
Xeris Biopharma Holdings (XERS) United States $0.845B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.757B 0.00
Bioventus (BVS) United States $0.750B 19.47
Xencor (XNCR) United States $0.750B 0.00
Cronos Group (CRON) Canada $0.692B 0.00
KalVista Pharmaceuticals (KALV) United States $0.574B 0.00
Organogenesis (ORGO) United States $0.548B 0.00
USANA Health Sciences (USNA) United States $0.510B 10.37
Savara (SVRA) United States $0.478B 0.00
Elite Pharmaceuticals (ELTP) United States $0.465B 0.00
Akebia Therapeutics (AKBA) United States $0.454B 0.00
Relay Therapeutics (RLAY) United States $0.444B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.442B 0.00
Verve Therapeutics (VERV) United States $0.406B 0.00
Zevra Therapeutics (ZVRA) United States $0.405B 0.00
Siga Technologies (SIGA) United States $0.391B 6.68
Tourmaline Bio (TRML) United States $0.391B 0.00
Altimmune (ALT) United States $0.385B 0.00
Oruka Therapeutics (ORKA) United States $0.384B 0.00
Aldeyra Therapeutics (ALDX) United States $0.343B 0.00
Heron Therapeutics (HRTX) United States $0.335B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.321B 19.14
Amylyx Pharmaceuticals (AMLX) United States $0.314B 0.00
OmniAb (OABI) United States $0.293B 0.00
Aquestive Therapeutics (AQST) United States $0.287B 0.00
Esperion Therapeutics (ESPR) United States $0.285B 36.00
CytoDyn (CYDY) United States $0.283B 0.00
ProKidney (PROK) United States $0.256B 0.00
Innate Pharma SA (IPHYF) France $0.243B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.235B 73.50
Nature's Sunshine Products (NATR) United States $0.232B 27.28
Wellgistics Health (WGRX) United States $0.224B 0.00
Avita Medical (RCEL) United States $0.213B 0.00
Profound Medical (PROF) Canada $0.175B 0.00
Nanobiotix S.A (NBTX) France $0.169B 0.00
MediWound (MDWD) Israel $0.168B 0.00
Aclaris Therapeutics (ACRS) United States $0.165B 0.00
Korro Bio (KRRO) United States $0.163B 0.00
Inhibikase Therapeutics (IKT) United States $0.163B 0.00
Lyell Immunopharma (LYEL) United States $0.159B 0.00
Protara Therapeutics (TARA) United States $0.157B 0.00
4D Molecular Therapeutics (FDMT) United States $0.150B 0.00
Larimar Therapeutics (LRMR) United States $0.138B 0.00
Nektar Therapeutics (NKTR) United States $0.127B 0.00
Journey Medical (DERM) United States $0.123B 0.00
Champions Oncology (CSBR) United States $0.120B 19.73
Enanta Pharmaceuticals (ENTA) United States $0.118B 0.00
Regulus Therapeutics (RGLS) United States $0.116B 0.00
Lexeo Therapeutics (LXEO) United States $0.115B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.115B 0.00
Telomir Pharmaceuticals (TELO) United States $0.096B 0.00
VAXART, INC (VXRT) United States $0.093B 0.00
Achieve Life Sciences (ACHV) Canada $0.093B 0.00
OptiNose (OPTN) United States $0.092B 0.00
Avalo Therapeutics (AVTX) United States $0.085B 0.00
Arch Biopartners (ACHFF) Canada $0.082B 0.00
Cardiol Therapeutics (CRDL) Canada $0.080B 0.00
Galectin Therapeutics (GALT) United States $0.077B 0.00
Inotiv (NOTV) United States $0.075B 0.00
Cassava Sciences (SAVA) United States $0.072B 0.00
ESSA Pharma (EPIX) Canada $0.070B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.069B 0.00
Nutriband (NTRB) United States $0.068B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.065B 0.00
Assertio Holdings (ASRT) United States $0.065B 0.00
Acrivon Therapeutics (ACRV) United States $0.064B 0.00
Vivani Medical (VANI) United States $0.062B 0.00
Pyxis Oncology (PYXS) United States $0.060B 0.00
Unicycive Therapeutics (UNCY) United States $0.060B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.059B 0.00
Fractyl Health (GUTS) United States $0.058B 0.00
PMV Pharmaceuticals (PMVP) United States $0.057B 0.00
Context Therapeutics (CNTX) United States $0.055B 0.00
Gain Therapeutics (GANX) United States $0.053B 0.00
AleAnna (ANNA) United States $0.052B 0.00
Metagenomi (MGX) United States $0.051B 0.00
ElectroCore (ECOR) United States $0.048B 0.00
Rafael Holdings (RFL) United States $0.047B 0.00
Dominari Holdings (DOMH) United States $0.044B 0.00
Iterum Therapeutics (ITRM) Ireland $0.043B 0.00
Prelude Therapeutics (PRLD) United States $0.042B 0.00
Century Therapeutics (IPSC) United States $0.041B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.041B 0.00
Surrozen (SRZN) United States $0.038B 0.00
SCYNEXIS (SCYX) United States $0.037B 0.00
NRx Pharmaceuticals (NRXP) United States $0.035B 0.00
Tempest Therapeutics (TPST) United States $0.034B 0.00
CASI Pharmaceuticals (CASI) China $0.033B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.032B 0.00
Karyopharm Therapeutics (KPTI) United States $0.031B 0.00
FibroGen (FGEN) United States $0.031B 0.00
PolyPid (PYPD) Israel $0.028B 0.00
DURECT (DRRX) United States $0.025B 0.00
VYNE Therapeutics (VYNE) United States $0.024B 0.00
Mural Oncology (MURA) Ireland $0.022B 0.00
Natural Alternatives (NAII) United States $0.021B 0.00
Enlivex Therapeutics (ENLV) Israel $0.021B 0.00
Jupiter Neurosciences (JUNS) United States $0.020B 0.00
BioVie (BIVI) United States $0.018B 0.00
Mannatech (MTEX) United States $0.017B 6.90
Lipocine (LPCN) United States $0.017B 0.00
Vivos Therapeutics (VVOS) United States $0.017B 0.00
MEI Pharma (MEIP) United States $0.015B 0.00
GlycoMimetics (GLYC) United States $0.014B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.013B 0.00
Scienture Holdings (SCNX) United States $0.013B 0.00
Carisma Therapeutics (CARM) United States $0.013B 0.00
Citius Pharmaceuticals (CTXR) United States $0.013B 0.00
Incannex Healthcare (IXHL) Australia $0.012B 0.00
Minerva Neurosciences (NERV) United States $0.012B 8.95
TherapeuticsMD (TXMD) United States $0.011B 0.00
Biomerica (BMRA) United States $0.010B 0.00
Cosmos Health (COSM) United States $0.010B 0.00
Mangoceuticals (MGRX) United States $0.010B 0.00
BioLineRx (BLRX) Israel $0.010B 0.00
ProPhase Labs (PRPH) United States $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 2.89
Relmada Therapeutics (RLMD) United States $0.009B 0.00
Phio Pharmaceuticals (PHIO) United States $0.009B 0.00
Nuvilex (PMCB) United States $0.009B 0.00
Talphera (TLPH) United States $0.008B 0.00
Traws Pharma (TRAW) United States $0.008B 0.00
Lyra Therapeutics (LYRA) United States $0.008B 0.00
Indaptus Therapeutics (INDP) United States $0.008B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
Ainos (AIMD) United States $0.008B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.007B 0.00
Klotho Neurosciences (KLTO) United States $0.006B 0.00
Plus Therapeutics (PSTV) United States $0.006B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.006B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Aptorum Group (APM) United Kingdom $0.004B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.003B 0.00
Conduit Pharmaceuticals (CDT) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Alaunos Therapeutics (TCRT) United States $0.002B 0.00
CERo Therapeutics Holdings (CERO) United States $0.002B 0.00
Heatwurx (PCSA) United States $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.002B 0.00
SHINECO (SISI) China $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
TNF Pharmaceuticals (TNFA) United States $0.001B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.001B 0.00
Petros Pharmaceuticals (PTPI) United States $0.001B 0.00
TransCode Therapeutics (RNAZ) United States $0.000B 0.00
Aditxt (ADTX) United States $0.000B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00